TUZISTRA XR (Vernalis Therapeutics, Inc.)


Welcome to the PulseAid listing for the TUZISTRA XR drug offered from Vernalis Therapeutics, Inc.. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Vernalis Therapeutics, Inc.
NON-PROPRIETARY NAME: codeine polistirex and chlorpheniramine polistirex
SUBSTANCE NAME: CODEINE PHOSPHATE ANHYDROUS; CHLORPHENIRAMINE MALEATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
ROUTE: ORAL
DOSAGE FORM: SUSPENSION, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-05-31
END MARKETING DATE: 0000-00-00


TUZISTRA XR HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTUZISTRA XR from Vernalis Therapeutics, Inc.
LABELER NAME: Vernalis Therapeutics, Inc.
DEA SCHEDULE: CIII
ACTIVE STRENGTH: 14.7; 2.8(mg/5mL; mg/5mL)
START MARKETING DATE: 2015-05-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69442-480_49121b33-5e2e-403f-93e6-2d27c2d1c4f6
PRODUCT NDC: 69442-480
APPLICATION NUMBER: NDA207768

Other CODEINE PHOSPHATE ANHYDROUS; CHLORPHENIRAMINE MALEATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Vernalis Therapeutics, Inc.TUZISTRA XR